Slovenia
Industry
In addition to a EUR49mn (US$61mn) reduction in its healthcare budget in early June, the Slovenian Ministry of Health has now proposed a series of pharmaceutical cost-containment measures....
2010-07-02BMI has introduced greater clarity to its core views for the Pharmaceuticals & Healthcare. Short-term core views concern the period through to the end of the 2011-2013 patent cliff,...
2010-03-15Industry
Slovenian pharmaceutical company Lek, a division of Novartis's generic arm Sandoz, has opened a new US$3.8mn biopharmaceutical production facility to produce biosimilar epoetin alfa....
2010-03-12Industry
The Slovenian government approved a draft Health Services Act in March 2010, laying the groundwork for system reform in the country. The act introduces a number of reforms that will...
2010-03-09Companies
Slovenian generic drugmaker Krka plans to continue its strong organic growth strategy during 2010, while also eyeing potential takeover opportunities. Chief Executive Jože Colarič...
2010-02-04Industry
BMI forecasts that pharmaceutical sales in Emerging Europe will grow by 125% over the next decade, representing a compound annual growth rate (CAGR) of 8.43%. With global sales projected...
2010-01-05Industry
Slovenia-based generic drugmaker Krka has been criticised by Lithuania's Ethical Pharmaceutical Companies Association (EFA) for failing to comply with the country's 'Code of Pharmaceutical...
2010-01-04Industry
BMI's regional outlook for pharmaceutical companies in Emerging Europe has improved marginally, following an update to our Pharmaceuticals & Healthcare Business Environment Ratings....
2009-10-30
